NORTHERN TRUST CORP - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$85,587
+12.6%
30,458
+21.8%
0.00%
Q2 2023$76,030
-75.2%
25,010
-84.7%
0.00%
Q1 2023$307,120
+80.7%
163,362
-2.0%
0.00%
Q4 2022$170,004
-62.8%
166,670
-4.1%
0.00%
Q3 2022$457,000
-37.7%
173,738
+6.8%
0.00%
Q2 2022$734,000
-54.6%
162,683
-1.0%
0.00%
Q1 2022$1,618,000
-37.0%
164,342
-2.2%
0.00%
Q4 2021$2,569,000
+128.4%
168,045
+102.5%
0.00%
Q3 2021$1,125,000
-17.5%
82,987
-10.6%
0.00%
Q2 2021$1,363,00092,7840.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 682,923$10,032,0001.61%
SECTORAL ASSET MANAGEMENT INC 711,000$10,445,0000.84%
Logos Global Management LP 507,923$7,461,0000.63%
Artal Group S.A. 2,064,262$30,324,0000.62%
Cormorant Asset Management, LP 1,215,847$17,264,0000.59%
Eventide Asset Management 1,561,092$22,411,0000.30%
Blackstone Inc. 8,089,315$118,832,0000.27%
Avidity Partners Management LP 436,363$6,410,0000.17%
VIKING GLOBAL INVESTORS LP 3,289,617$48,324,0000.15%
HHLR ADVISORS, LTD. 853,344$12,536,0000.13%
View complete list of TALARIS THERAPEUTICS INC shareholders